ZA91504B - Method for percutaneous delivery of ibuprofen using hydroalcoholic gel - Google Patents

Method for percutaneous delivery of ibuprofen using hydroalcoholic gel

Info

Publication number
ZA91504B
ZA91504B ZA91504A ZA91504A ZA91504B ZA 91504 B ZA91504 B ZA 91504B ZA 91504 A ZA91504 A ZA 91504A ZA 91504 A ZA91504 A ZA 91504A ZA 91504 B ZA91504 B ZA 91504B
Authority
ZA
South Africa
Prior art keywords
ibuprofen
percutaneous delivery
hydroalcoholic gel
hydroalcoholic
gel
Prior art date
Application number
ZA91504A
Other languages
English (en)
Inventor
Stephen J Wisniewski
J Wisniewski Stephen
Mark Gemborys
Gemborys Mark
Original Assignee
Mcneil Ppc Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mcneil Ppc Inc filed Critical Mcneil Ppc Inc
Publication of ZA91504B publication Critical patent/ZA91504B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ZA91504A 1990-01-24 1991-01-23 Method for percutaneous delivery of ibuprofen using hydroalcoholic gel ZA91504B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/469,649 US5093133A (en) 1990-01-24 1990-01-24 Method for percutaneous delivery of ibuprofen using hydroalcoholic gel

Publications (1)

Publication Number Publication Date
ZA91504B true ZA91504B (en) 1992-09-30

Family

ID=23864566

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA91504A ZA91504B (en) 1990-01-24 1991-01-23 Method for percutaneous delivery of ibuprofen using hydroalcoholic gel

Country Status (11)

Country Link
US (1) US5093133A (pt)
EP (1) EP0439344A3 (pt)
JP (1) JPH04210914A (pt)
KR (1) KR910014117A (pt)
AU (1) AU632655B2 (pt)
CA (1) CA2033499C (pt)
GR (1) GR1001025B (pt)
IE (1) IE910232A1 (pt)
NZ (1) NZ236797A (pt)
PT (1) PT96550A (pt)
ZA (1) ZA91504B (pt)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5210099A (en) * 1991-02-11 1993-05-11 American Home Products Corporation Analgesic compositions
US5240917A (en) * 1991-04-03 1993-08-31 Keimowitz Rudolph M Suppression of thromboxane levels by percutaneous administration of aspirin
AU3062392A (en) * 1991-11-04 1993-06-07 Novo Nordisk A/S Pdgf gel formulation
US5248494A (en) * 1992-06-10 1993-09-28 Young Pharmaceuticals Inc. Method of reducing anthralin induced inflammation and staining
US6071896A (en) * 1992-06-16 2000-06-06 Gundersen Clinic, Ltd. Suppression of thromboxane levels by percutaneous administration of aspirin
JPH09504018A (ja) * 1993-10-20 1997-04-22 ザ ブーツ カンパニー ピーエルシー 抗掻痒薬としてのイブプロフェンおよびフルルビプロフェン
DE4336299A1 (de) * 1993-10-25 1995-05-11 Arbo Robotron Medizin Technolo Gelkörper zur percutanen Verabreichung, insbesondere von Medikamenten
IT1265001B1 (it) * 1993-12-16 1996-10-17 Zambon Spa Composizione farmaceutica per uso topico contenente acido (s)-2-(4- isobutilfenil) propionico
GB9404248D0 (en) * 1994-03-05 1994-04-20 Boots Co Plc Pharmaceutical formulations
JP3782834B2 (ja) * 1994-10-26 2006-06-07 株式会社トクホン 鎮痛抗炎症貼付剤
US5807568A (en) * 1994-12-27 1998-09-15 Mcneil-Ppc, Inc. Enhanced delivery of topical compositions containing flurbiprofen
US5654337A (en) * 1995-03-24 1997-08-05 II William Scott Snyder Topical formulation for local delivery of a pharmaceutically active agent
US5702720A (en) * 1995-12-22 1997-12-30 Minnesota Mining And Manufacturing Company Transdermal device for the delivery of flurbiprofen
US5976566A (en) * 1997-08-29 1999-11-02 Macrochem Corporation Non-steroidal antiinflammtory drug formulations for topical application to the skin
US5888523A (en) * 1997-09-22 1999-03-30 Biocontrol, Inc. Topical non-steroidal anti-inflammatory drug composition
US6083996A (en) * 1997-11-05 2000-07-04 Nexmed Holdings, Inc. Topical compositions for NSAI drug delivery
US6294188B1 (en) 1998-07-09 2001-09-25 Aviana Biopharm Inc. Methods involving changing the constitutive and stimulated secretions of the local reproductive system of women
US6368618B1 (en) * 1999-07-01 2002-04-09 The University Of Georgia Research Foundation, Inc. Composition and method for enhanced transdermal absorption of nonsteroidal anti-inflammatory drugs
DE10025328A1 (de) * 2000-05-23 2001-12-06 Lohmann Therapie Syst Lts Acetylsalicylsäure enthaltendes superfizielles therapeutisches System zur Behandlung von Hautschmerzen
IN191090B (pt) * 2000-08-29 2003-09-20 Ranbanx Lab Ltd
WO2003013453A1 (en) * 2001-08-09 2003-02-20 Lamirsa S.A. Use of cationic surfactants in cosmetic preparations
US6551615B1 (en) * 2001-10-18 2003-04-22 M/S. Strides Arcolab Limited Dexibuprofen-containing soft gelatin capsules and process for preparing the same
US20050049291A1 (en) * 2001-10-23 2005-03-03 Mukesh Kumar Process for the preparation of pharmaceutical compositions for topical delivery of cyclooxygenase-2-enzyme inhibitors
US20030232097A1 (en) * 2002-06-17 2003-12-18 Strides Inc. Oily wax matrix suspension formulation comprising ibuprofen free acid and potassium salt of ibuprofen
WO2005044227A1 (en) * 2003-11-05 2005-05-19 Glenmark Pharmaceuticals Limited Topical pharmaceutical compositions
US20050196450A1 (en) 2004-03-04 2005-09-08 Elka Touitou Method and composition for burned skin
US20070053984A1 (en) * 2005-03-03 2007-03-08 Monique Spann-Wade Topical gels compositions
EP1858503B1 (en) * 2005-03-03 2013-09-04 Green, Monique Renata Topical gels compositions
US20080095831A1 (en) * 2006-08-10 2008-04-24 Mc Graw Thomas L Topical formulation of multilamellar vesicles composition for percutaneous absorption of pharmaceutically active agent
US20080317684A1 (en) * 2006-09-06 2008-12-25 Isw Group, Inc. Topical Compositions
PT2211837E (pt) * 2007-06-08 2014-02-17 Troikaa Pharmaceuticals Ltd Uma solução tópica não aquosa de diclofenaco e processo para preparar a mesma
DE102007034976A1 (de) 2007-07-26 2009-01-29 Bayer Healthcare Ag Arzneimittel zur transdermalen Anwendung bei Tieren
HUP0700828A2 (en) * 2007-12-20 2010-01-28 Richter Gedeon Nyrt Transdermal pharmaceutical compositions containing tolperisone alone and in combination
AU2009251743A1 (en) * 2008-05-30 2009-12-03 Fairfield Clinical Trials, Llc Method and composition for skin inflammation and discoloration
EP2373346B1 (en) * 2008-09-10 2019-06-12 BioChemics, Inc. Ibuprofen for topical administration
MX349176B (es) 2008-09-22 2017-07-14 Biochemics Inc Suministro transdermico de farmaco empleando un osmolito y un agente vasoactivo.
GB0921686D0 (en) * 2009-12-11 2010-01-27 Reckitt Benckiser Healthcare I Topical formulation
US9205041B2 (en) 2011-05-03 2015-12-08 Aponia Laboratories, Inc. Transdermal compositions of ibuprofen and methods of use thereof
FR2990134B1 (fr) * 2012-05-07 2014-11-21 Anaconda Pharma Composition pharmaceutique d'un inhibiteur du virus du papillome
KR101894891B1 (ko) * 2012-11-30 2018-09-04 동아에스티주식회사 흡수가 증가된 덱시부프로펜 에멀젼 함유 겔 제형
US9012402B1 (en) 2014-06-11 2015-04-21 James Blanchard Gel for topical delivery of NSAIDs to provide relief of musculoskeletal pain and methods for its preparation
JP2018502837A (ja) * 2014-12-03 2018-02-01 アールエックスアイ ファーマシューティカルズ コーポレーション 遺伝子調節アプローチを用いた円形脱毛症の処置方法
US11007161B1 (en) 2014-12-31 2021-05-18 Eric Morrison Ibuprofen nanoparticle carriers encapsulated with hermatic surfactant films
US10561627B2 (en) 2014-12-31 2020-02-18 Eric Morrison Ibuprofen nanoparticle carriers encapsulated with hermetic surfactant films
US10596117B1 (en) 2014-12-31 2020-03-24 Eric Morrison Lipoleosomes as carriers for aromatic amide anesthetic compounds
WO2016149126A1 (en) 2015-03-13 2016-09-22 The Board Of Trustees Of The Leland Stanford Junior University Ltb4 inhibition to prevent and treat human lymphedema
US10744174B1 (en) * 2016-03-16 2020-08-18 Robert Alonso Composition(s) and method(s) for topically treating pain
US10821075B1 (en) 2017-07-12 2020-11-03 James Blanchard Compositions for topical application of a medicaments onto a mammalian body surface
AU2019239949A1 (en) * 2018-03-19 2020-10-15 Cage Bio Inc. Ionic liquid compositions for treatment of rosacea
CA3160206A1 (en) * 2019-12-09 2021-06-17 Futura Medical Developments Limited Topical composition and methods of measuring the cooling ability of a topical composition
WO2023081539A1 (en) 2021-11-08 2023-05-11 Weiyong Li Transdermal drug delivery system for delivering a drug to a patient

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE363786C (de) * 1919-10-03 1922-11-13 Lancia & Co Lenkerverbindung der Federn mit dem Untergestell von Kraftfahrzeugen
US4185100A (en) * 1976-05-13 1980-01-22 Johnson & Johnson Topical anti-inflammatory drug therapy
GB2075837B (en) * 1980-05-14 1984-03-14 Hisamitsu Pharmaceutical Co Topical pharmaceutical gel containing anti-inflammatory analgesic agents
DE3243546A1 (de) * 1982-11-25 1984-05-30 Bayer Ag, 5090 Leverkusen Antimykotische mittel in gelform zur behandlung von pilzinfektionen der mundhoehle
JPS59222409A (ja) * 1983-06-01 1984-12-14 Nippon Redarii Kk 消炎鎮痛ゲル軟膏剤
JPS60185712A (ja) * 1984-03-06 1985-09-21 Kiyuushin Seiyaku Kk 消炎鎮痛用軟膏剤
DE3532562A1 (de) * 1985-09-12 1987-03-12 Dolorgiet Gmbh & Co Kg Transdermal resorbierbare, wasserhaltige zubereitungen von arylpropionsaeurederivaten und verfahren zur herstellung derselben
DE3639038C2 (de) * 1986-11-14 1997-02-06 Helmut Dr Lukas Verwendung von S-(+)-Ibuprofen zur schnellen Behandlung humaner Schmerzen
US4851444A (en) * 1987-07-10 1989-07-25 Analgesic Associates Onset-hastened/enhanced analgesia
GB2217595B (en) * 1988-04-21 1991-11-20 American Cyanamid Co Antiinflammatory gel

Also Published As

Publication number Publication date
IE910232A1 (en) 1991-07-31
AU6991991A (en) 1991-07-25
GR910100027A (en) 1992-06-25
NZ236797A (en) 1993-03-26
KR910014117A (ko) 1991-08-31
EP0439344A3 (en) 1991-09-25
AU632655B2 (en) 1993-01-07
JPH04210914A (ja) 1992-08-03
US5093133A (en) 1992-03-03
CA2033499A1 (en) 1991-07-25
EP0439344A2 (en) 1991-07-31
GR1001025B (el) 1993-03-31
PT96550A (pt) 1991-10-15
CA2033499C (en) 1996-10-01

Similar Documents

Publication Publication Date Title
GR910100027A (en) Method for percutaneous delivery of ibuprofen using hydroalcoholic gel
EP0431080A4 (en) Compositions and methods for drug delivery and chromatography
AU1267792A (en) Pressure-compensated fluid administering apparatus
AU2904289A (en) Excreting apparatus
GB2214429B (en) Apparatus and method for administering fluids
EP0759306A3 (en) Device for administering medication
AU2816589A (en) Self-regulated therapeutic agent delivery system and method
EP0499260A3 (en) Procedure for hydrolyzing keratin
ZA915644B (en) Gel formulations
AU589739B2 (en) Direct delivery system for dental materials
HU9301404D0 (en) Method for preparing medical preparatives
IL98803A0 (en) Gel formulations
EP0276813A3 (en) Method for preparing film coated pharmaceutical preparations and method for improving properties thereof
GB2271592B (en) Gel method for preventing water-influx
AU7080587A (en) Therapeutic compositions for veterinary use
IL75921A0 (en) Gelatinous pharmaceutical preparations
HUT65838A (en) Pharmateutical preparations containing tnf inhibitors
AU6524386A (en) Method for administering vaccines and compositions therefor
AU3011692A (en) Horseshoes and method for their preparation
AU7793791A (en) Pharmaceutical composition for use in treating pain
EP0436203A3 (en) Percutaneous gel preparation
PL308307A1 (en) 3-substituted 2-oxyindolo-1-carboxylamide pharmaceutical preparations
EP0505201A3 (en) Gelling agent for liquid gel concentrate
AU616198B2 (en) Appetite suppressant dentifrice
HU9203477D0 (en) Method for preparing water-dissoluble pharmaceutical preparaive